Annual SGA
$14.76 M
+$2.01 M+15.79%
December 31, 2023
Summary
- As of February 8, 2025, ANTX annual SGA is $14.76 million, with the most recent change of +$2.01 million (+15.79%) on December 31, 2023.
- During the last 3 years, ANTX annual SGA has risen by +$13.50 million (+1067.11%).
- ANTX annual SGA is now at all-time high.
Performance
ANTX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.48 M
-$247.00 K-6.62%
September 30, 2024
Summary
- As of February 8, 2025, ANTX quarterly SGA is $3.48 million, with the most recent change of -$247.00 thousand (-6.62%) on September 30, 2024.
- Over the past year, ANTX quarterly SGA has dropped by -$157.00 thousand (-4.31%).
- ANTX quarterly SGA is now -14.06% below its all-time high of $4.05 million, reached on March 31, 2023.
Performance
ANTX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$709.29 M
-$60.70 M-9.36%
September 30, 2024
Summary
- As of February 8, 2025, ANTX TTM SGA is -$709.29 million, with the most recent change of -$60.70 million (-9.36%) on September 30, 2024.
- Over the past year, ANTX TTM SGA has dropped by -$723.64 million (-5042.43%).
- ANTX TTM SGA is now -1396.89% below its all-time high of -$47.38 million.
Performance
ANTX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ANTX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.8% | -4.3% | -5042.4% |
| 3 y3 years | +1067.1% | -4.3% | -5042.4% |
| 5 y5 years | +1067.1% | -4.3% | -5042.4% |
ANTX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +216.3% | -14.1% | +95.5% | -1396.9% | at low |
| 5 y | 5-year | at high | +1067.1% | -14.1% | +768.8% | -1396.9% | at low |
| alltime | all time | at high | +1067.1% | -14.1% | +768.8% | -1396.9% | at low |
AN2 Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.48 M(-6.6%) | $14.75 M(-1.8%) |
| Jun 2024 | - | $3.73 M(+2.5%) | $15.02 M(+4.7%) |
| Mar 2024 | - | $3.64 M(-6.5%) | $14.35 M(-2.8%) |
| Dec 2023 | $14.76 M(+15.8%) | $3.90 M(+3.9%) | $14.76 M(+1.2%) |
| Sep 2023 | - | $3.75 M(+22.5%) | $14.59 M(+2.9%) |
| Jun 2023 | - | $3.06 M(-24.4%) | $14.18 M(-3.9%) |
| Mar 2023 | - | $4.05 M(+8.9%) | $14.76 M(+15.7%) |
| Dec 2022 | $12.75 M | $3.72 M(+11.4%) | $12.75 M(+18.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $3.34 M(-8.1%) | $10.81 M(+19.4%) |
| Jun 2022 | - | $3.63 M(+77.3%) | $9.05 M(+43.3%) |
| Mar 2022 | - | $2.05 M(+15.0%) | $6.32 M(+35.3%) |
| Dec 2021 | $4.67 M(+269.0%) | - | - |
| Dec 2021 | - | $1.78 M(+12.3%) | $4.67 M(+61.7%) |
| Sep 2021 | - | $1.59 M(+76.7%) | $2.89 M(+122.2%) |
| Jun 2021 | - | $898.00 K(+123.9%) | $1.30 M(+223.9%) |
| Mar 2021 | - | $401.00 K | $401.00 K |
| Dec 2020 | $1.26 M | - | - |
FAQ
- What is AN2 Therapeutics annual SGA?
- What is the all time high annual SGA for AN2 Therapeutics?
- What is AN2 Therapeutics annual SGA year-on-year change?
- What is AN2 Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly SGA year-on-year change?
- What is AN2 Therapeutics TTM SGA?
- What is the all time high TTM SGA for AN2 Therapeutics?
- What is AN2 Therapeutics TTM SGA year-on-year change?
What is AN2 Therapeutics annual SGA?
The current annual SGA of ANTX is $14.76 M
What is the all time high annual SGA for AN2 Therapeutics?
AN2 Therapeutics all-time high annual SGA is $14.76 M
What is AN2 Therapeutics annual SGA year-on-year change?
Over the past year, ANTX annual SGA has changed by +$2.01 M (+15.79%)
What is AN2 Therapeutics quarterly SGA?
The current quarterly SGA of ANTX is $3.48 M
What is the all time high quarterly SGA for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly SGA is $4.05 M
What is AN2 Therapeutics quarterly SGA year-on-year change?
Over the past year, ANTX quarterly SGA has changed by -$157.00 K (-4.31%)
What is AN2 Therapeutics TTM SGA?
The current TTM SGA of ANTX is -$709.29 M
What is the all time high TTM SGA for AN2 Therapeutics?
AN2 Therapeutics all-time high TTM SGA is -$47.38 M
What is AN2 Therapeutics TTM SGA year-on-year change?
Over the past year, ANTX TTM SGA has changed by -$723.64 M (-5042.43%)